Intron Biotechnology, Inc.
4 clinical trials · Sponsor
◉ Watch Intron Biotechnology, Inc.
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011 (NCT03585803) | Intron Biotechnology, Inc. | 2018-06-11 |
| A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers (NCT03446053) | Intron Biotechnology, Inc. | 2018-02-07 |
Track Intron Biotechnology, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.